Sahm Nasseri

Sahm is head of Business Development and Strategy at Generate:Biomedicines. He has significant experience across biotech, large pharma and strategy consulting and is passionate about unlocking the full potential of science through value-creating collaborations and clearly defined strategy.

Before joining Generate, Sahm spent several years in biotech. Most recently, he served as Chief Business Officer at Biotheryx, a privately held targeted protein degradation biotech where he led business development and strategy efforts for the company including establishing the company’s first collaboration, an oncology focused platform collaboration with Incyte Corporation. Prior to this, Sahm worked at Merck & Co. for seven years as a leader across business development, investor relations and strategy functions involving extensive commercial drug development experience. During this time, he established and led the global strategy and operations team for Merck’s growing oncology organization and served as interim Vice President and Global Product Leader for Merck’s portfolio of HPV Vaccines. Before Merck, Sahm was a strategy consultant with McKinsey & Company in Australia. Sahm holds a B.S. in chemical engineering from the University of New South Wales in Sydney and an MBA from Columbia Business School in New York City.